Agenda released for ADMET 2016: Linking ADME and PK with safety to an overall assessment of risk and benefit

Top Quote SMi Group reports: (09.02.2016, London): The agenda has now been released for SMi's 11th annual ADMET conference and exhibition which will take place on the 13th and 14th June 2016 in London, UK. End Quote
  • (1888PressRelease) February 10, 2016 - ADME and toxicology testing are one of the most important research activities related to new drug discovery. Ensuring a good ADMET study will accelerate approval and therefore commercialisation of your drug product - and hence pharmacokinetics remain at the forefront of drug formulation and development.

    Since the pharmaceutical and biotechnology companies are utilising innovative technologies, ADME and toxicology screening at the early stages of drug discovery and development has become even more imperative.

    This event will explore novel and emerging non-clinical ADME approaches, structure based prediction of ADME properties, PK/PD modelling to validate drug targets, toxicity and much more.

    For further information or to register please visit the event website or contact Matthew Apps on +44 (0) 207 827 6093 or mapps ( @ ) smi-online dot co dot uk

    Nick Plant, Reader in Systems Biology, University of Surrey (CHAIRMAN)
    Thierry Lave, Head DMPK Discovery and Development Project Leaders (CNS/CVM), Roche
    Friedemann Schmidt, R&D DSAR Preclinical Safety, Sanofi-Aventis
    Kunal Taskar, Senior Investigator, DMPK, GSK
    Karelle Menochet, Principal Scientist DMPK, UCB Pharma
    Laurent Salphati, Senior Scientist, Genentech
    Carl Petersson, DMPK NCE Senior Designer, Merck Serono
    Lena Gustavsson, Head of Sections Drug-Drug Interactions, Lundbeck

    To download the full agenda please visit the event website

    Discover application of PBPK to drug development in rare diseases
    Review the role of drug transporters in drug delivery to CNS diseases
    Learn about better models for understanding, predicting and avoiding drug induced liver injury
    Discuss in silico approaches to evidence-based mechanistic modelling
    Analyse early dose predictions - a valuable tool in risk assessment and optimisation of small molecules

    Running alongside the conference is a half-day post-conference workshop. The workshop entitled 'Molecular properties and intermolecular interactions in virtual ADMET assessment' will be led by Mire Zloh, Head of Medicinal and Analytical Chemistry Research Group, University of Hertfordshire and Teresa Barata, Research Associate, UCL School of Pharmacy

    To register or for further information on the workshop/leaders please visit the event website

    For those interested in attending, there is currently an early bird offer available saving 400 off of the conference price which expires on the 29th of February.

    ADMET 2016 is sponsored by Corning and Sekisui XenoTech.

    For sponsorship enquiries, contact Alia Malick on +44 (0) 207 827 6168 or amalick ( @ ) smi-online dot co dot uk

    For delegate enquiries, contact Matthew Apps on +44 (0) 207 827 6093 or mapps ( @ ) smi-online dot co dot uk

    For media enquiries, contact Zoe Gale on +44 (0) 207 827 6132 or zgale ( @ ) smi-online dot co dot uk

    11th annual ADMET conference and exhibition
    13-14 June 2016
    London, UK
    Contact e-mail: zgale ( @ ) smi-online dot
    Contact tel: +44 (0) 207 827 6093

    About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at

  • FB Icon Twitter Icon In-Icon
Contact Information